Purpose: To evaluate the ocular surface characteristics and corneal microstructure in patients with newly diagnosed Graves disease (GD) with no evidence of active thyroid eye disease (TED).
G raves disease (GD) is an autoimmune disorder characterized by thyroid dysfunction triggered by autoantibodies against the thyroid-stimulating hormone receptor. Graves orbitopathy (GO) is the most frequent extrathyroidal manifestation of GD. 1 Ocular surface disease (OSD) and ocular discomfort are common features in GO. Previous studies have suggested that hyposecretory and evaporative mechanisms related to retraction of the eyelid, proptosis, lagophthalmos, excessive corneal exposure, and lacrimal gland impairment give rise to dry eye in GD. [1] [2] [3] Dry eye occurs most frequently in patients suffering from thyroid dysfunction, and until recently it was thought to be essentially associated with an increased amount of exposed ocular surface related to globe protrusion. 4 However, recent research indicates that inflammation of the ocular surface may be an additional cause of OSD in patients with GD and that occult thyroid eye disease (TED) may lead to dry eye symptoms. [5] [6] [7] In vivo confocal microscopy (IVCM) is a noninvasive imaging technique to evaluate the corneal microstructure in health and diseased states, including epithelial disorders, stromal degenerative and dystrophic disease, endothelial pathologies, corneal deposits, infections, and traumatic changes of the cornea. 8 There is a strong correlation between thyroid-stimulating autoantibody levels and clinical activity score of GD and GO, as suggested in previous studies. 1, 9 However, to the best of our knowledge, no study has looked into the ocular surface and corneal structural changes in patients with newly diagnosed GD with no evidence of active TED. Thus, this study was undertaken to investigate whether there was any deterioration in ocular surface parameters with or without accompanying corneal microstructural changes in patients with GD who were referred for ophthalmic examination.
MATERIALS AND METHODS
Eighty eyes of 40 patients with newly diagnosed GD who were referred from the Endocrinology Department and 80 eyes of 40 healthy control subjects without GD were included in this study between January 2013 and April 2014. The tenets of the Declaration of Helsinki were followed throughout the study. Informed consent was obtained from all patients and the study was carried out with approval from the institutional review board. All patients underwent complete ophthalmic examination, including refraction, slitlamp examination, intraocular pressure determination, fundus examination, ocular motility evaluation, and Hertel exophthalmometry. Activity and severity measures were based on the classical features of inflammation according to the consensus statement of the European Group on Graves orbitopathy (EUGOGO) recommendations. 10 Briefly, sightthreatening GD is defined by the presence of dysthyroid optic neuropathy and/or corneal breakdown, and moderate-tosevere GD is defined by the presence of moderate to severe tissue involvement, exophthalmos $3 mm above normal for race and gender, lid retraction $2 mm, and diplopia. Mild GD is defined by the presence of exophthalmos ,3 mm above normal for race and gender, lid retraction ,2 mm, mild soft tissue or corneal involvement, or transient diplopia. 10 None of the patients had active thyroid eye disease including proptosis, dysmotility, diplopia, or optic neuropathy. Patients who were treated with radioactive iodine or those who had thyroidectomy, those who were on any topical medication, those who had any pathologic ocular findings, those with a history of ocular surface surgery or ocular trauma, those who had been treated with systemic drugs that may have corneal toxicity or any topical drops, those who were using contact lenses, and those who had any systemic disease that may adversely affect subbasal nerve plexus were excluded from the study. Control subjects were recruited during routine screening visits and had no history of ocular disease, pathologic ocular findings, or systemic disease.
Ocular surface testing of all patients was carried out by an observer masked to the presence or absence of GD. Tests were carried out in the order of standard tear break-up time (BUT) testing, LG staining of the conjunctiva and cornea, and Schirmer I test with topical anesthesia. All tests were performed in exactly the same order for all subjects in 1 session and at the same time of the day. BUT measurement was obtained after application of sterile fluorescein strips wetted with saline solution. The patient was instructed to blink several times for a few seconds and BUT was measured as the time between the last blink and the appearance of the first corneal dry spot. Ocular surface staining was evaluated after application of an LG strip in the lower conjunctival sac. Using white light, staining of the cornea and the conjunctiva was graded between 0 and 5 according to the Oxford Scheme. 11 Schirmer I test was performed after instillation of a topical anesthetic (proparacaine hydrochloride 0.5%, Alcaine; Alcon Laboratories Inc, Puurs, Belgium). Sterilized strips of filter paper were placed in the inferior fornix, between the lateral third and the middle third of the eyelid, for 5 minutes with the patient looking straight ahead. Patients were also assessed using the Ocular Surface Disease Index (OSDI; Allergan Inc, Irvine, CA) questionnaire with respect to the severity of their subjective symptoms. OSDI was developed to provide a rapid assessment of the severity of symptoms of OSD and their impact on vision-related function. 12 Briefly, the 12 items of the OSDI questionnaire were graded on a scale of 0 to 4: 0 indicates the presence of symptoms none of the time; 1, some of the time; 2, half the time; 3, most of the time; and 4, all the time. Total OSDI score was calculated for each patient using the formula: OSDI = (sum of scores for all questions answered) · 25/(total number of questions answered). Thus, OSDI was scored on a scale of 0 to 100.
In Vivo Confocal Microscopy
IVCM of corneal sections was performed with a Confoscan 3.0 (Nidek, Vigonza, Italy) attached to an immersion lens (Achroplan 40·/0.75 W; Zeiss, Oberkochen, Germany). The technique is described in detail elsewhere. 13 The immersion lens had a working distance of 1.98 mm, numerical aperture of 0.75, and front surface area of 16.61 mm². Data were collected for both eyes, and 1 eye for each patient was chosen at random. Before examination, each cornea was anesthetized with proparacaine hydrochloride (Alcaine 0.5%; Alcon Laboratories Inc). After application of Viscotears (Carbomer 0.2%; Novartis, Basel, Switzerland) as a coupling agent to the applanating lens, the full thickness of the central cornea was scanned. For each subject, 4 to 6 complete full-layer corneal scans were obtained. The images represented an area of 450 · 340 mm, had a lateral resolution of 1 mm, and a depth resolution of 10 mm. The mean magnification obtained was 500· on a 15-inch display (1024 · 768 pixels).
Image Analysis
Central corneal images of all participants were obtained and the 2 best-focused images from epithelium, subbasal nerve plexus, anterior stroma, intermediate stroma, posterior stroma, and endothelium were evaluated. Keratocyte density was determined using a manual method of counting images of cell nuclei in a predefined area of confocal images, using the software provided with Confoscan 3.0. A boundary box positioned at the image center with fixed dimensions (200 · 300 mm) and a size of 0.060 mm 2 was used to quantify the keratocyte, endothelial cell, and basal epithelial cell densities. The size of the box was kept constant for all study subjects. Cells that overlapped the boundary box were counted at only the superior and the left half of the box. Keratocyte densities were measured at the anterior (0-100 mm posterior to the basal epithelium), middle (half the distance between the basal epithelium and the endothelium), and posterior (0-100 mm anterior to the endothelium) stromal layers. Subbasal nerves were evaluated in the images that contained the greatest number of nerve fibers. Subbasal nerve densities were evaluated with respect to the number of long nerve fibers (LNFs) per frame, total number of nerve branches (NBs) per frame, and also by determining subbasal nerve fiber length (mm) per frame. Three nonoverlapping images per eye were selected for subbasal nerve analysis. The images were exported from the Confoscan 3 device, and density measurements were performed using the NeuronJ software (http://www.imagescience.org/meijering/software/neuronj/). Subbasal nerve tortuosity was graded into 4 groups, with grade 1 representing perfectly straight nerves and grade 4 representing grossly tortuous nerves with significant convolutions throughout their course.
Statistical Analysis
Data were evaluated in collaboration with the Department of Biostatistics. Data analysis was performed by SPSS 15.0 software package (Statistical Package for Social Sciences; SPSS Inc IBM, Armonk, NY). Descriptive statistics were expressed as mean 6 SD according to the assumption of normal distribution. An independent sample t test was performed to compare group means. A Chi-square test was used to examine association between groups for categorical variables. For nonnormally distributed data, a Mann-Whitney U test was used in group comparisons. Correlations between the variables were evaluated using the Spearman index of linear correlation. P , 0.05 was accepted as statistically significant.
RESULTS
Forty patients with newly diagnosed GD without presence of active thyroid eye disease (TED) (29 women, 11 men) and 40 control subjects (26 women, 14 men) were enrolled in this study. Mean age of patients with GD and control subjects were 35.4 6 11.2 years (range, 20-57 years) and 33.8 6 10.3 years (range, 17-56 years), respectively. There were no significant differences between the 2 groups with respect to age (P = 0.490, t test) and gender (P = 0.469, x 2 test). Mean Hertel values were higher (17.2 6 2.6) in the study group compared with the control subjects (15.7 6 1.9) (P = 0.001).
The clinical characteristics and ocular surface parameters of subjects with and without GD are highlighted in Table 1 . OSDI, BUT, and LG staining scores were found to be significantly lower in patients with GD compared with control subjects, whereas Schirmer values were not different between the 2 groups (Table 1) .
Patients with GD had significantly lower cell densities in the basal epithelium compared with the healthy subjects (P , 0.001). The differences in the densities of the anterior (P = 0.330), mid-stromal (P = 0.878), and posterior stromal keratocytes (P = 0.708) and the endothelium (P = 0.811) were not significant compared with the corresponding layers of the control subjects. The results of corneal cell densities are outlined in Table 2 .
The number of subbasal LNFs (P = 0.484) and total nerve number of nerve fibers (P = 1.000) were not found to be significantly different, whereas total nerve density of all main nerves and their branches were found to be significantly lower in the corneas of patients with GD compared with those of the control subjects (P , 0.001) ( Table 3 ). In addition, the subbasal nerve plexus of patients with GD appeared significantly more tortuous than those of control subjects (P , 0.001).
The mean duration between the onset of symptoms of hyperthyroidism and the diagnosis of GD was 10.4 6 7.6 months (2-36 months). There was a statistically significant negative correlation between disease duration and BUT (rho = -0.273, P = 0.014) and a positive correlation between LG staining scores (rho = 0.329, P = 0.003), whereas no statistically significant correlation was found between Schirmer test values (rho = 0.017, P = 0.884) or OSDI scores (rho = 20.194, P = 0.084) and the duration of the GD. A significant reduction in BUT (rho = 20.238, P = 0.003) and epithelial cell density (rho = 20.174, P = 0.029) was found with increasing Hertel measurements. In addition, there was a positive correlation between OSDI scores and Hertel values (rho = 0.328, P = 0.003).
DISCUSSION
Ocular surface changes in GD are a consequence of both abnormal eyelid-globe interactions and ocular surface inflammation. 1, 5, 14 Increased ocular surface exposure due to proptosis and upper eyelid retraction are considered to be the main causes of OSD. 2, 3 Dry eye prevalence has been reported to be as high as 60% in TED. Exophthalmos, lid retraction, and palpebral fissure height were found to be the most important risk factors for ocular surface damage. 7 Recent studies have also shown evidence for ocular surface impairment in patients with nonexophthalmic thyroid disease. 15, 16 In addition, dry eye symptoms and ocular inflammation were found to be early manifestations of underlying occult thyroid disease in patients presenting with dry eyes. 5 Thus, we aimed to investigate whether there was evidence for ocular surface damage in corneas of patients with newly diagnosed GD who had not received any treatment for GD. We were able to demonstrate a significant impairment in ocular surface parameters as manifested by BUT, LG staining, and OSDI questionnaire results. In agreement with our study, in a recent study by Bruscolini et al, 15 a significant deterioration in Schirmer test, BUT, and OSDI scores was found in patients with newly diagnosed GD. They reported a significant reduction in BUT and basal epithelial cell density with increasing Hertel values. We also found a significant change in BUT results, but not in Schirmer test values. Although none of the patients had proptosis in our study, the mean Hertel values were higher in our patients in the study group compared with control subjects.
In addition, we found a negative correlation between BUT and Hertel values and a positive correlation between OSDI scores and Hertel exophthalmometry measurements. The decreased tear BUT values and normal Schirmer test scores support the presence of impaired tear film stability in the study group. These results confirm that the ocular surface alterations associated with GD seem to be mainly evaporative in nature due to the increased eyelid width and corneal exposure. In accordance with our results, a significant decrease in superficial epithelial cell density in the bulbar conjunctiva with IVCM and positive correlation with tear BUT indicate tear film instability in patients with inactive GO. 17 In a retrospective observational case series among patients presenting with dry eye symptoms, the incidence of TED was found to be 3.9%. 5 Furthermore, in the same study by Gupta et al, 5 an abnormal Schirmer test result was present in 81% of patients with TED, giving rise to the suggestion that occult TED is a potential cause of inflammatory ocular surface disease. In agreement with the results by Gupta et al, Xu et al 18 showed higher fluorescein staining and lower Schirmer test results in both active and inactive TED and a higher proportion of grade 2 to 3 changes by impression cytology in active TED. In the study by Villani et al, 6 the OSDI score was significantly higher, the Schirmer test and BUT values were found to be significantly lower in patients with GO, but there was no significant difference between active versus inactive GO in terms of the ocular surface parameters. In accordance with the results of the study by Villani et al, 6 it has been suggested that ocular surface inflammation and autoimmune mechanisms may be the main cause for the impairments on the ocular surface parameters in a subset of patients with GO.
In addition to the changes in ocular surface parameters, basal epithelial cell density and subbasal nerve plexus densities were also found to be decreased in the study patients with GD. The subbasal nerve plexus is fundamental in maintaining epithelial cell integrity, and the subnormal subbasal nerve plexus as observed in our study may be responsible for decreased epithelial cell density. 19 Furthermore, increased nerve tortuosity may reflect increased metabolic activity of nerve fibers due to inflammationrelated epithelial changes. 19 There is only one similar published study that looked into the corneal microstructure of patients with active versus inactive GO using IVCM. 6 In that study, the authors were able to show significant alterations in cell densities in superficial and basal epithelial layers as well as keratocytes between patients with GO and control subjects; however, no such differences were observed between active and inactive GO except the density of activated keratocytes. 6 In agreement with our results, they showed a lower number of nerve fibers and an increased degree of tortuosity in the subbasal nerve plexus of the study group, but no such difference could be demonstrated in active versus inactive disease. Alterations in corneal layers of patients with GO were thought to be a consequence of eyelid retraction and exophthalmos. 6 In the light of our results and of those obtained in previous studies, both inflammatory and evaporative mechanisms may be responsible for ocular surface changes and corneal microstructural alterations in GD.
The number of studies in the literature that have evaluated changes in the ocular surface in patients with newly diagnosed GD is limited. 15, 16, 18 In these studies, it has been demonstrated that increased inflammatory cells and squamous metaplasia resulted in ocular surface damage in a population diagnosed with GD with or without accompanying TED by conjunctival impression cytology and clinically. However, to the best of our knowledge, our report is the first in the literature to detail both ocular surface characteristics and in vivo ultrastructural corneal changes including cell densities in different layers of the cornea and subbasal nerve plexus in corneas of patients with newly diagnosed GD with no evidence of active TED. One limitation of the present study is that measurements were obtained at 1 time point; it may be more valuable to obtain a longer course of the ocular surface followup over time in this study population to understand the progressive nature of ocular surface damage in GD. Another limitation was that tear film osmolarity could not be measured in this study. Measurement of tear osmolarity may have provided additional information on the underlying cause of observed ocular surface changes in patients with inactive GD.
In conclusion, the findings of the present study demonstrate deterioration in ocular surface parameters in patients with GD even without overt signs of ocular involvement as well as the use of IVCM in detecting the early corneal microstructural changes in these patients. Awareness of subtle dry eye findings in this particular subset of patients with GD may facilitate a more vigilant follow-up plan and the institution of early dry eye treatment modalities. Careful evaluation of the ocular surface of patients with newly diagnosed TED is warranted, especially in cases with borderline Hertel measurements.
